NCT01422408View on ClinicalTrials.gov

Fluocinonide Cream in Treating Symptoms of Vaginal Dryness and Painful Sexual Intercourse In Patients With Breast Cancer Undergoing Hormone Therapy

PHASE2CompletedINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Breast Carcinoma
Interventions
DRUG

Fluocinonide Cream

Given topically

PROCEDURE

Management of Therapy Complications

Receive fluocinonide cream

OTHER

Questionnaire Administration

Ancillary studies

Trial Locations (1)

97239

OHSU Knight Cancer Institute, Portland

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

OHSU Knight Cancer Institute

OTHER

NCT01422408 - Fluocinonide Cream in Treating Symptoms of Vaginal Dryness and Painful Sexual Intercourse In Patients With Breast Cancer Undergoing Hormone Therapy | Biotech Hunter | Biotech Hunter